Gheorghe Doros, PhDAssociate Professor, Biostatistics
BiographyGheorghe Doros is Associate Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company’s Drug Discovery and Toxicology department. Professor Doros’s interests focus on Clinical Trials, Bayesian Statistics, asymptotic statistics, testing, and computational statistics. He is involved in projects that evaluate the effects of physical and emotional stresses of caregiving on physical and psychological health. He also serves as a statistical consultant to Boston Medical Center’s Amyloid Center and as biostatistician for the Boston University Clinical Research Training (CREST) project. At BUSPH, he teaches the course in Computational Statistics and Generalized Linear Models.
- Boston Medical Center
- Yale University, PhD
- Yale University, MA
- University of Bucharest , MS
- University of Bucharest , BS
- Published on 12/4/2015
Lew RA, Liang MH, Doros G. Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier. Arthritis Res Ther. 2015; 17:345.
- Published on 10/27/2015
Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E. Anticholinergic vs Long-Acting ß-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. JAMA. 2015 Oct 27; 314(16):1720-30.
- Published on 10/20/2015
Moreira CC, Farber A, Rybin D, Doros G, Kalish J, Eberhardt RT, Siracuse JJ, Hamburg NM. Racial Differences in Treatment Approaches and Mortality Following Arterial Trauma. Vasc Endovascular Surg. 2015 Oct; 49(7):180-7.
- Published on 10/17/2015
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Mortality risk with dual antiplatelet therapy? Lancet. 2015 Oct 17; 386(10003):1533-4.
- Published on 10/2/2015
Yassin A, Almehmadi Y, Saad F, Doros G, Gooren L. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men. Clin Endocrinol (Oxf). 2016 Jan; 84(1):107-14.
- Published on 10/1/2015
Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study. J Nerv Ment Dis. 2015 Oct; 203(10):762-8.
- Published on 9/1/2015
Traish AM, Haider KS, Doros G, Haider A. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Horm Mol Biol Clin Investig. 2015 Sep 1; 23(3):85-96.
- Published on 8/24/2015
Eslami MH, Rybin DV, Doros G, Farber A. The Association of Publication of Center for Medicaid and Medicare Services Guidelines for Carotid Artery Angioplasty and Stenting (CAS) and CREST Results on the Utilization of CAS in Carotid Revascularization. Ann Vasc Surg. 2015 Nov; 29(8):1606-13.
- Published on 7/29/2015
Saad F, Yassin A, Doros G, Haider A. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies. Int J Obes (Lond). 2016 Jan; 40(1):162-70.
- Published on 7/18/2015
Nzara R, Rybin D, Doros G, Didato S, Farber A, Eslami MH, Kalish JA, Siracuse JJ. Perioperative Outcomes in Patients Requiring Iliac Conduits or Direct Access for Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2015 Nov; 29(8):1548-53.
View 107 more publications:View full profile at BUMC